Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age

Rheumatology International

Volumn 36, Issue 1, 2016, Pages 117-124

  Medeiros, Marta Maria das Chagas ^a,b   Xavier de Oliveira, Ídila Mont’Alverne ^a,c   Ribeiro, Ádilla Thaysa Mendes ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b Federal University of Ceará ^*  (Brazil)

^c Dr José Frota Institute   (Brazil)

Author keywords

Epidemiology; Metabolic syndrome; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; CHLOROQUINE; CYCLOPHOSPHAMIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PREDNISONE;

ADULT; AGE DISTRIBUTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BRAZIL; CLINICAL EXAMINATION; COHORT ANALYSIS; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LABORATORY TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; UNIVERSITY HOSPITAL; AGE; COMORBIDITY; CROSS-SECTIONAL STUDY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MIDDLE AGED; RISK FACTOR;

ADULT; AGE FACTORS; BRAZIL; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS; SMOKING;

EID: 84953837325     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-015-3316-z     Document Type: Article

References (43)

1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al (2005) Diagnosis and management of the metabolic syndrome. An American heart association/national heart, Lung, and blood institute scientific statement. Circulation 112(17):2735–2752
2. Reilly MP, Rader DJ (2003) The metabolic syndrome: more than the sum of its parts? Circulation 108(13):1546–1551
3. Miranda PJ, De-Fronzo RA, Califf RM, Guyton JR (2005) Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J 149(1):33–45
4. Rask-Madsen C, Dominguez H, Ihlemann N, Hermann T, Kober L, Torp-Pedersen C (2003) Tumor necrosis factor-alpha inhibits insulin´s stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. Circulation 108(15):1815–1821
5. El-Magadmi M, Bodill H, Ahmad Y, Durrington PN, Mackness M, Walker M et al (2004) Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 110(4):399–404
6. Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S et al (2003) Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 349(25):2407–2415
7. Ahmad Y, Shelmerdine J, Bodill H, Lunt M, Pattrick MG, Teh LS et al (2007) Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype. Rheumatology 46(6):983–988
8. Svenungsson E, Jensen-Urstad K, Heimburger M, Silveira A, Hamsten A, de Faire U et al (2001) Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 104(16):1887–1893
9. Bruce IN, Urowitz MB, Gladman DD, Ibañez D, Steiner G (2003) Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto risk factor study. Arthritis Rheum 48(11):3159–3167
10. Azevedo GZ, Gadelha RG, Vilar MJ (2007) Metabolic syndrome in systemic lupus erythematosus: lower prevalence in Brazil than in the USA. Ann Rheum Dis 66(11):1542
11. Vadacca M, Margiotta D, Rigon A, Cacciapaglia F, Coppolino G, Amoroso A et al (2009) Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors. J Rheumatol 36(2):295–297
12. Bellomio V, Spindler A, Lucero E, Berman A, Sueldo R, Berman H et al (2009) Metabolic syndrome in Argentinean patients with systemic lupus erythematosus. Lupus 18(11):1019–1025
13. Mok CC, Poon WL, Lai JPS, Wong CK, Chiu SM, Wong CK et al (2010) Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus. Scand J Rheumatol 39(1):42–49
14. Lozovoy MA, Simão AN, Hohmann MS, Simão TN, Barbosa DS, Morimoto HK et al (2011) Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome. Lupus 20(13):1356–1364
15. Sabio JM, Zamora-Pasadas M, Jiménez-Jáimez J, Albadalejo F, Vargas-Hitos J, Rodriguez del Aguila MDM et al (2008) Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain. Lupus 17(9):849–859
16. El Magadmi M, Ahmad Y, Turkie W, Yates AP, Sheikh N, Bernstein RM et al (2006) Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus. J Rheumatol 33(1):50–56
17. Negrón AM, Molina MJ, Mayor AM, Rodríguez VE, Vilá LM (2008) Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico. Lupus 17(4):348–354
18. Bultink IEM, Turkstra F, Diamant M, Dijkmans BA, Voskuyl AE (2008) Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus. Clin Exp Rheumatol 26(1):32–38
19. Zonana-Nacach A, Santana-Sahagún E, Jiménez-Balderas FJ, Camargo-Coronel A (2008) Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus. J Clin Rheumatol 14(2):74–77
20. Telles RW, Lanna CCD, Ferreira GA, Ribeiro A (2010) Metabolic syndrome in patients with systemic lupus erythematosus: association with traditional risk factors for coronary heart disease and lupus characteristics. Lupus 19(7):803–809
21. Parker B, Urowitz MB, Gladman DD, Lunt M, Bae SC, Sanchez-Guerrero J et al (2013) Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Ann Rheum Dis 72(8):1308–1314
22. Chung CP, Avalos I, Oeser A, Gebretsadik T, Shintani A, Raggi P et al (2007) High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 66(2):208–214
23. Parker B, Ahmad Y, Shelmerdine J, Edlin H, Yates AP, Teh LS et al (2011) An analysis of the metabolic syndrome phenotype in systemic lupus erythematosus. Lupus 20(14):1459–1465
24. Hochberg MC (1997) Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725
25. Gladmann DD, Ibañez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288–291
26. Gladman DD, Ginzler EM, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39(3):363–369
27. Vidigal FC, Bressan J, Babio N, Salas-Savado J (2013) Prevalence of metabolic syndrome in Brazilian adults: a systematic review. BMC Public Health 13:1198
28. Gómez M, Ramirez M, Disdier O (2006) Prevalence of the metabolic syndrome among a determined Puerto Rican population. P R Health Sci J 25(2):111–116
29. Baron AD (2002) Insulin resistance and vascular function. J Diabetes Complicat 16(1):92–102
30. Leeuw K, Freire B, Smit AJ, Bootsma H, Kallenberg CG, Bijl M (2006) Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus. Lupus 15(10):675–678
31. Bessant R, Duncan R, Ambler G, Swanton J, Isenberg DA, Gordon C et al (2006) Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: a case–control study. Arthritis Rheum 55(6):892–899
32. Gheita TA, Raafat HA, Sayed S, El-Fishawy H, Nasrallah MM, Abdel-Rasheed E (2013) Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Z Rheumatol 72:172–177
33. Sun K, Liu J, Ning G (2012) Active smoking and risk of metabolic syndrome: a meta-analysis of prospective studies. PLoS One 7(10):e47791
34. Mendelsohn ME (2002) Protective effects of estrogen on the cardiovascular system. Am J Cardiol 89(12A):12E–17E
35. Sabio JM, Vargas-Hitos JA, Navarrete N, Hidalgo-Tenorio C, Jimenes-Alonso J, de las Nieves GLV (2010) Effects of low or medium-dose of prednisone on insulin resistance in patients with systemic lupus erythematosus. Clin Exp Rheumatol 28(4):483–489
36. Espinola RG, Pierangeli SS, Gharavi AE, Harris EN (2002) Hydroxychloroquine reverses platet activation induced by human IgG antiphospholipid antibodies. Thromb Haemost 87(3):518–522
37. Petri M, Magder LS (2013) Association between hydroxychloroquine exposure and incidence of diabetes mellitus in systemic lupus erythematosus. Arthritis Rheum 65(S 10):S770
38. Cairoli E, Rebella M, Danese N, Garra V, Borba EF (2012) Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect. Lupus 21(11):1178–1182
39. Penn SK, Kao AH, Schott LL, Elliott JR, Toledo FG, Kuller L et al (2010) Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 37(6):1136–1142
40. Grundy SM (2006) Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47(6):1093–1100
41. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SR (2003) The metabolic syndrome: prevalence and associated risk factors findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 163(4):427–436
42. Dallongeville J, Cottel D, Ferrieres J, Arveiler D, Bingham A, Ruidavets JB et al (2005) Household income is associated with the risk of metabolic syndrome in a sex-specific manner. Diabetes Care 28(2):409–415
43. Marquezine GF, Oliveira CM, Pereira AC, Krieger JE, Mill JG (2008) Metabolic syndrome determinants in na urban population from Brazil: social class and gender-specific interaction. Int J Cardiol 129(2):259–265